Welcome to our dedicated page for Carvana SEC filings (Ticker: CVNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to track how Carvana funds thousands of cars, manages loan securitizations and discloses insider sales? Each Carvana annual report 10-K stretches over 200 pages and every 10-Q dives deep into inventory turns and gross profit per unit. Finding the right note on debt covenants or the exact timing of executive stock transactions can consume an entire afternoon.
Stock Titan solves that problem. Our AI-powered summaries translate dense disclosures into plain language, so Carvana SEC filings are explained simply. Need the latest Carvana quarterly earnings report 10-Q filing? It鈥檚 here, paired with side-by-side metrics and instant red-line changes. Want live alerts on Carvana Form 4 insider transactions real-time? We ping you the moment a director buys or sells. From Carvana 8-K material events explained to a Carvana proxy statement executive compensation breakdown, every form is updated the second EDGAR publishes.
Why does that matter? Carvana鈥檚 business hinges on capital availability, inventory velocity and consumer demand鈥攁ll laid bare in its disclosures. Our platform highlights:
- Securitization proceeds and cash-flow bridges from the latest 10-Q
- Unit economics and GPU trends pulled from the 10-K鈥�Carvana annual report 10-K simplified
- AG真人官方-time tracking of Carvana insider trading Form 4 transactions and Carvana executive stock transactions Form 4
- Concise Carvana earnings report filing analysis with AI-generated charts
- Keyword search across auditor notes for recall-related costs
Whether you鈥檙e monitoring liquidity before the next bond maturity or just understanding Carvana SEC documents with AI, Stock Titan delivers every filing, every insight鈥攏o dealership waiting room required.
Form 4/A highlights insider equity changes at The OLB Group, Inc. (OLB):
- Chairman, CEO and 10% owner Ronny Yakov acquired 4,685,029 common shares on 06-02-25 (Code J) directly from the company鈥檚 treasury at a deemed fair-value price of $1.31 per share. Shares were issued in lieu of cash to satisfy outstanding liabilities, debt financing, accrued interest and bonuses.
- On 06-30-25 he gifted 878,074 shares (Code G) for no consideration.
- Earlier, on 05-28-25, Yakov returned 1,021 Series A Preferred shares for cancellation (Code D). Each preferred share was convertible into 111.11 common shares, eliminating up to 113,444 potential new common shares.
After the reported transactions Yakov holds 4,378,014 common shares directly. His beneficial ownership also includes 227,003 Series A warrants ($90 strike, exp. 08-11-25), 56,751 Series B warrants ($45 strike, exp. 08-11-25) and 20,000 vested stock options ($0.03 strike).
The filing amends the Form 4 dated 01-26-24 to include the 2025 transactions.
Carvana Co. (CVNA) Form 144 filing: insider Thomas Taira has notified the SEC of his intent to sell up to 10,000 common shares through Morgan Stanley on or after 01 Aug 2025. The proposed block carries an estimated market value of $3.75 million and will trade on the NYSE. Carvana has 138.08 million shares outstanding, so the sale equals roughly 0.007% of total shares.
The shares derive from three restricted-stock vesting events (1 May, 1 Jun, 1 Jul 2024) that cumulatively delivered 10,000 shares to the filer. Under Rule 144 aggregation rules, Taira鈥檚 recent activity is material: over the last three months he already disposed of 80,878 shares for gross proceeds of about $24.04 million, with individual trades ranging from 5,000 to 35,000 shares between 01 May and 06 Jun 2025.
The filer certifies that no undisclosed adverse information is known and that the sale will comply with Rule 144 conditions. No other operational or financial metrics are included in this notice.
Form 4 鈥� Carvana Co. (CVNA) filed 01-Aug-2025 shows CEO, Director and 10% owner Ernest C. Garcia III sold Class A shares through two family trusts.
- Total shares sold: 2,700 on 31-Jul-2025.
- Price range: $396.78-$412.77; estimated proceeds 鈮� $1.1 million.
- Post-sale holdings: 591,440 shares in the Ernest Irrevocable 2004 Trust III and 691,440 shares in the Multi-Generational Trust III (鈮�1.28 million combined).
- Sales were executed under a Rule 10b5-1 plan adopted 13-Dec-2024.
No derivatives were traded, and Garcia remains a >10% shareholder. The disposals equal roughly 0.21% of his indirect stake, suggesting limited impact on control but offering a minor sentiment signal for investors monitoring insider activity.
Robinhood Markets, Inc. (HOOD) insider Daniel Martin Gallagher has filed a Form 144 indicating an intent to sell up to 225,000 common shares through Morgan Stanley Smith Barney on or after 01-Aug-2025. At the 07-31-2025 market price used in the filing, the shares represent an aggregate value of roughly $22.49 million.
The planned sale equals 鈮�0.03% of the 773,963,666 shares outstanding. Gallagher has already sold 75,000 shares over the past three months for total gross proceeds of $5.34 million at gradually rising prices. All shares being sold were acquired via recent restricted-stock vesting under the company鈥檚 registered equity plan.
Under Rule 144, the filer attests to possessing no material non-public information. Although modest relative to HOOD鈥檚 float, consecutive insider dispositions can influence sentiment, so investors may monitor additional filings or ownership changes.
Amkor Technology Inc. (AMKR) 鈥� SEC Form 4 filing (07/30/2025): The 2023 Grantor Retained Annuity Trust of founder James J. Kim (10% owner group) gift-distributed 2,711,000 AMKR common shares to James J. Kim. The transfer is coded 鈥淕鈥� (bona-fide gift) with no consideration ($0). Post-distribution, the trust鈥檚 direct holdings fall to 876,004 shares. Susan Y. Kim serves as sole trustee; filing states it should not be deemed an admission of beneficial ownership of other group members鈥� shares.
The transaction represents roughly 1% of Amkor鈥檚 ~250 M diluted share count and does not involve an open-market sale, so immediate trading-pressure is limited. However, the shift places a sizable block directly under James J. Kim鈥檚 control, potentially increasing future liquidity if he opts to sell. Overall, the filing reflects estate/ownership restructuring rather than a valuation-driven move and carries minimal near-term impact on Amkor鈥檚 operations or capital structure.
Playboy, Inc. (Nasdaq: PLBY) has filed a Rule 424(b)(5) prospectus supplement to reactivate its at-the-market (ATM) equity program. Under an amended Sales Agreement with Roth Capital Partners dated 8 Aug 2024 and amended 18 Jul 2025, the company may sell up to $15 million in common stock (par $0.0001) from time to time. No shares have been sold under the prior August 2024 supplement, so the full $15 million capacity is now available.
Shares will be offered at prevailing market prices; Roth will receive a 3.0 % commission and is deemed an underwriter. At the 17 Jul 2025 closing price of $1.83, the program could issue roughly 8.4 million new shares, expanding pro-forma outstanding shares to 鈮�102.4 million (vs. 93.9 million at 31 Mar 2025) and implying up to ~9 % dilution.
Use of proceeds: working capital, general corporate purposes, possible debt repayment or acquisitions. Net tangible book value was -$1.97/share as of 31 Mar 2025; the illustrative financing lifts this to -$1.67/share, yielding immediate dilution of $3.45/share.
Key risks highlighted include continued Nasdaq listing compliance (price and board independence), further equity dilution from options/RSUs, and broad management discretion over proceeds. The supplement incorporates the company鈥檚 2024 Form 10-K and Q1-25 Form 10-Q by reference.
Butterfly Network (BFLY) Q2-25 10-Q highlights
- Revenue: $23.4 m, +9% YoY; product sales +14% on higher iQ3 pricing and Octiv chip deliveries; software & services flat.
- Gross margin: 63.7% vs 58.6% prior-year as software amortization fell and manufacturing efficiencies improved.
- Operating expenses: $31.0 m (-3% YoY). R&D -12% to $8.3 m; G&A -9% to $9.1 m; Sales & Marketing +19% to $11.6 m as the company scales commercial teams.
- Net loss: 鈥�$13.8 m (-12% YoY); EPS 鈥�$0.06 vs 鈥�$0.07.
- Cash & equivalents: $148.1 m at 30 Jun 25, up from $88.8 m at 31 Dec 24 after a $81 m January share offering; operating cash burn for H1-25 narrowed to $18.8 m from $30.7 m.
- Balance sheet: Assets $313 m, equity $233 m; warrant liabilities down to $1.2 m from $2.7 m.
- Key metrics: Gross profit $14.9 m (+18%); H1 revenue $44.6 m (+14%); H1 net loss 鈥�$27.8 m (vs 鈥�$37.5 m).
Management attributes margin gains to cost controls and lower software amortization. Litigation and severance drove $2.0 m of 鈥淥ther鈥� costs. With ~250 m diluted shares outstanding, dilution risk rises, but the strengthened cash position extends runway beyond 12 months.
Nurix Therapeutics, Inc. (NRIX) has filed a Form 144 disclosing that shareholder Johannes Van Houte plans to sell 5,402 common shares through Morgan Stanley Smith Barney, with an approximate market value of $60,826.52. The transaction is expected on or about 01 Aug 2025 on the NASDAQ. With 76,449,355 shares outstanding, the proposed sale equals roughly 0.007 % of the company鈥檚 equity.
The notice also lists two prior sales in the last three months: 4,304 shares on 30 Jul 2025 for $51,695.34 and 6,198 shares on 02 May 2025 for $70,242.55鈥攖ogether totaling 10,502 shares and $121,938. These shares, like the new lot, originated from restricted stock units acquired on 30 Jul 2025. The filer attests to possessing no undisclosed material adverse information and may be trading under a Rule 10b5-1 plan, indicating procedural compliance rather than a sudden shift in outlook.
On 29 Jul 2025, Standard BioTools Inc. (LAB) filed an 8-K disclosing new executive retention incentives.
- CEO Michael Egholm is granted 3,000,000 RSUs: 25 % vests 1 Aug 2026; the remaining 75 % vests in three equal annual tranches thereafter, subject to continuous service.
- CFO Alex Kim is granted 1,500,000 RSUs: 40 % vests 20 Jul 2026 and 60 % vests 20 Jul 2027.
- Grants are issued under the amended 2011 Equity Incentive Plan and governed by the 2023/2024 Change-of-Control & Severance Plans.
- The Human Capital Committee also raised Mr. Kim鈥檚 annual cash bonus target to 80 % of base salary, retroactive to 1 Jan 2025.
No operating or financial results accompanied the filing. While the equity awards strengthen leadership retention, they add share-based compensation expense and create potential dilution for existing shareholders.
Carvana Co. (CVNA) 鈥� Form 4 insider activity. On 29 & 30 Jul 2025, 10 % owner/director Ernest C. Garcia II exchanged a total of 100,000 Class A Units of Carvana Group for 100,000 Class A shares under the 2017 Exchange Agreement.
Immediately after each conversion, he sold the full 50,000-share blocks (aggregate 100,000 shares) through a Rule 10b5-1 trading plan at weighted-average prices ranging from $329.32 to $344.40, realising roughly $33-34 million in gross proceeds. His direct Class A share balance fell back to zero after the transactions.
The conversions required cancellation of 100,000 Class B super-voting shares, trimming Garcia鈥檚 Class B holdings from 35.39 million to 35.34 million. He still controls 8.0 million Class B shares and 10 million exchangeable Class A Units through ECG II SPE, LLC, plus 44.18 million Class A Units held directly.
Key takeaway: Large, pre-planned insider sales monetise ~$33 m of stock but do not meaningfully alter Garcia鈥檚 overall economic or voting position.
FAQ
What is the current stock price of Carvana (CVNA)?
What is the market cap of Carvana (CVNA)?
What is Carvana's core business?
How does Carvana generate revenue?
What sets Carvana apart from traditional car dealerships?
How does technology play a role in Carvana's operations?
What additional services does Carvana offer?
How does Carvana ensure cost savings for its customers?
Where is Carvana positioned in the used car market?
How are financing and insurance integrated into Carvana's model?
